Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seroyal is a premier provider of professional-grade dietary supplements and natural health products, serving healthcare practitioners for over 30 years. The company offers an extensive portfolio of evidence-based formulations through its core brands, including Genestra Brands, UNDA, Pharmax, and Wobenzym. Their product range spans multiple categories such as probiotics, vitamins, minerals, and homeopathic preparations designed for clinical application. Seroyal is a subsidiary of Atrium Innovations, which is part of the Nestlé Health Science family. The company is highly regarded for its commitment to scientific rigor, manufacturing excellence, and comprehensive practitioner education programs. By integrating nutritional science into holistic patient management, Seroyal remains a leader in the professional nutraceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seroyal.